What Is a Cardiogram and What Does It Measure?

A cardiogram, most commonly called an electrocardiogram (ECG or EKG), is a recording of the electrical signals that trigger every heartbeat. Skin electrodes pick up tiny voltage changes as electrical impulses sweep through the heart muscle, and the machine prints them as a series of waves on paper or a screen. Those waves tell clinicians how fast and how regularly the heart is beating, whether each chamber is contracting in the right sequence, and whether parts of the heart muscle are damaged or under strain. The test itself is painless, takes about ten seconds of actual recording for a standard version, and remains one of the most widely used diagnostic tools in medicine.

What the Machine Actually Picks Up

Every heartbeat begins with a small burst of electricity in the heart’s natural pacemaker, a cluster of cells in the upper right chamber. That electrical impulse spreads through the upper chambers, pauses briefly at a relay station between upper and lower chambers, then races through specialized fibers into the thick-walled lower chambers, causing them to contract and pump blood. Each phase produces a characteristic change in voltage that travels outward through the body and can be detected at the skin surface.

The signal is tiny, measured in millivolts. Willem Einthoven’s invention of the string galvanometer in 1901 was the breakthrough that made it possible to capture these minute currents with enough fidelity to be clinically useful; earlier instruments could only manage rudimentary measurements of limited value.¹ Modern ECG machines use digital amplifiers that are vastly more sensitive, but the basic principle has not changed: electrodes on the skin detect the sum of all the electrical currents flowing through heart muscle at each instant.

Research into the underlying physics has shown that the electrical signals largely travel along the long axes of cardiac muscle fibers rather than spreading uniformly in all directions.² This matters because it means the direction and size of the waves on your ECG tracing reflect not just whether the heart is beating, but the physical orientation and thickness of the muscle walls doing the beating.

Reading the Waves

A normal ECG tracing repeats a recognizable pattern with each heartbeat. Three main features stand out: the P wave, the QRS complex, and the T wave. Each one corresponds to a specific electrical event inside the heart.

P wave: A small, gentle bump that represents the electrical activation of the two upper chambers (atria). When the P wave is absent, oddly shaped, or erratic, it often signals an abnormal rhythm like atrial fibrillation.
QRS complex: The tall, sharp spike in the middle of each cycle. It represents the electrical activation of the two lower chambers (ventricles), the powerful pumping chambers that push blood to the lungs and the rest of the body. Because the ventricle walls are much thicker than the atrial walls, the QRS produces the largest voltage deflection.
T wave: A broader, softer wave after the QRS. It represents the ventricles resetting their electrical charge (repolarization) in preparation for the next beat. Changes in T wave shape can indicate reduced blood flow, electrolyte problems, or drug effects.

Beyond these individual waves, clinicians pay close attention to the time intervals between them. The PR interval, measured from the start of the P wave to the start of the QRS, tells you how long it takes the electrical signal to travel from the upper chambers through the relay station and into the ventricles. A PR interval that is too long suggests a conduction delay, commonly called a heart block. The QT interval, from the start of the QRS to the end of the T wave, reflects the total time the ventricles spend depolarizing and repolarizing. An abnormally long QT interval raises the risk of dangerous rhythm disturbances. Automated ECG software measures these intervals, though studies have found that different interpretation programs can disagree substantially, with clinically significant measurement errors differing by a factor of two across programs.³ That is why a clinician’s review of the tracing still matters even when the computer generates a report.

Why Twelve Leads Instead of One

The standard clinical ECG uses ten physical electrodes placed on the chest and limbs, which produce twelve different “views” of the heart’s electrical activity, known as leads. Each lead looks at the heart from a different angle. Think of it like photographing a building from twelve directions: some views highlight the front wall, others the side, others the base. Leads focused on the bottom of the heart may show damage there that leads looking at the side wall miss entirely.

This spatial information is one of the ECG’s greatest strengths. When a coronary artery becomes blocked during a heart attack, the affected region of heart muscle stops conducting electricity normally. The specific leads that show abnormal changes tell the doctor which artery is likely blocked and which wall of the heart is in jeopardy. ST-segment depression localized to a particular vascular territory, for example, can be a sign of a heart attack in the opposite wall even when the classic ST elevation is not obvious in the corresponding leads.⁴

Vectorcardiography (VCG) takes this spatial concept further by representing the heart’s electrical activity as a moving point tracing loops in three-dimensional space, capturing both spatial and temporal dynamics along three perpendicular body planes.⁵ Traditional 12-lead ECGs lack some of the spatial detail that VCG can provide, which has led researchers to develop 3D mapping approaches for QRS loops to better visualize ventricular electrical activity.⁶ VCG is not used routinely in most hospitals, but it remains a research tool and finds occasional clinical use when standard tracings are ambiguous.

Longer Monitoring for Elusive Arrhythmias

A standard ECG captures about ten seconds of heart rhythm. That is plenty if the problem is happening right then, but many arrhythmias are intermittent. Palpitations that come and go, brief episodes of atrial fibrillation, or pauses that only happen during sleep may never show up on a snapshot recording done in the office.

The traditional solution is a Holter monitor, a portable device worn for 24 hours that continuously records the heart rhythm. The limitation is obvious: one day of recording may still miss something that happens once a week. Wearable adhesive patches that record for seven to fourteen days significantly improve detection rates. In one study, a 14-day ECG patch detected relevant arrhythmias in about two-thirds of patients, compared to only 9% with a standard 24-hour Holter. Among 32 patients, the patch identified atrial fibrillation or atrial flutter in roughly one in five patients, while the Holter caught it in only one.⁷ Even a 7-day patch shows a clear advantage, with one study reporting an overall arrhythmia detection rate of about 35% for the patch versus 19% for a 24-hour Holter.⁸

Newer ambulatory systems using smartphone apps have also shown promise, picking up arrhythmias in more cases than conventional Holter monitors during head-to-head comparisons over the same recording period.⁹ The takeaway for patients is straightforward: if your doctor suspects an intermittent rhythm problem and a standard ECG comes back normal, longer monitoring with a patch or app-based system is the logical next step, not a repeat of the same ten-second test.

Smartwatch ECGs

Consumer smartwatches from several manufacturers now include single-lead ECG capability. You press your finger to the watch crown, hold still for 30 seconds, and the device generates a rhythm strip. These are real electrocardiograms, but they use a single electrical perspective rather than twelve, so the information they can provide is inherently more limited.

Where they shine is screening for atrial fibrillation. A systematic review and meta-analysis of the evidence found that smartwatches had a pooled sensitivity of about 95% and a pooled specificity of about 96% for detecting atrial fibrillation.¹⁰ Those are impressive numbers in a screening context. Individual device studies, however, reveal some nuance. One study of a smartwatch single-lead ECG found sensitivity of about 94% and specificity of about 82%, with a positive predictive value of only 55%, meaning almost half of the “atrial fibrillation” alerts were false alarms. Agreement with a clinical 12-lead ECG improved when unclassified tracings were reviewed by an electrophysiologist.¹¹

If your watch flags an irregular rhythm, the appropriate response is to follow up with your doctor for a clinical-grade ECG, not to panic or, conversely, to ignore it. A single-lead device cannot diagnose a heart attack, assess chamber enlargement, or evaluate most of the things a 12-lead ECG can. Think of it as a useful early warning system with a narrow but valuable skill set.

Detecting Heart Attacks

This is probably the most well-known use of the ECG. During a heart attack, part of the heart muscle is deprived of blood, and the electrical behavior of that tissue changes in predictable ways. The most dramatic sign is ST-segment elevation, where the flat line between the QRS and T wave lifts upward in the leads facing the damaged area. This finding, called a STEMI (ST-elevation myocardial infarction), triggers an emergency response because it typically means a major coronary artery is completely blocked and the muscle is dying in real time.

Not all heart attacks produce ST elevation. Some cause ST depression or T-wave inversion, patterns that still indicate trouble but may involve a partially blocked or temporarily spasming artery. The location of these changes across the twelve leads helps clinicians map the problem to a specific coronary artery territory.⁴ Old heart attacks also leave footprints: abnormal Q waves, which are deep initial negative deflections in leads facing the scarred region, can persist for years and tell a new doctor that damage happened at some point in the past.

Where the ECG Struggles With Heart Enlargement

One area where the ECG is surprisingly unreliable is detecting left ventricular hypertrophy, a thickening of the heart’s main pumping chamber that can result from long-standing high blood pressure, valve disease, or other chronic conditions. You might expect that a thicker muscle wall would produce bigger electrical signals, and it sometimes does, but the relationship is far from straightforward.

In the Framingham Heart Study, which examined over 4,600 people with echocardiographic confirmation, the overall sensitivity of traditional ECG voltage criteria for detecting true left ventricular hypertrophy was only about 7%, while specificity was nearly 99%.¹² In plainer terms, if you had true hypertrophy, the ECG missed it more than 90% of the time. But if the ECG said you had it, you almost certainly did. Obesity and smoking both reduced sensitivity further, probably because body fat and lung tissue attenuate the electrical signals before they reach the skin electrodes. Newer ECG criteria have improved somewhat, with one set achieving sensitivity around 62% while maintaining specificity above 90%.¹³ Even so, the majority of people with true chamber thickening may go undetected on ECG alone.¹⁴ This is one reason echocardiography or cardiac MRI is used when hypertrophy is suspected clinically.

How Medications and Electrolytes Change the Tracing

Your ECG is not just a snapshot of your heart’s wiring; it reflects the chemical environment your heart cells are sitting in. Potassium and calcium levels, in particular, directly affect how heart cells repolarize, and abnormalities in either electrolyte show up on the tracing. Low potassium flattens the T wave and may produce a prominent U wave (an extra bump after the T wave). High potassium does the opposite, producing tall, peaked T waves and, at dangerous levels, widening the QRS complex.

Many common medications prolong the QT interval, the stretch of time from the start of ventricular contraction to the end of electrical recovery. A long QT interval is concerning because it raises the risk of a specific dangerous arrhythmia. One large study found that patients taking a single QT-prolonging drug had an average QT interval about 11 milliseconds longer than those not taking one, and adding a second QT-prolonging drug added another 3 milliseconds on top of that. Low potassium, low calcium, and the use of loop diuretics were also independent risk factors for QT prolongation of at least 10 milliseconds.¹⁵

In patients with kidney disease, who often have electrolyte shifts and take multiple medications, the picture gets more complex. In this population, about three-quarters of clinical visits involved at least one QT-prolonging medication, and a third involved two or more. Specific drugs associated with measurable QT prolongation included amiodarone (a heart rhythm drug), several antidepressants, and certain diuretics, even after accounting for potassium and calcium levels.¹⁶ If you are on multiple medications and your ECG shows a long QT interval, your doctor may want to check your electrolytes and review your drug list before assuming the heart itself is the problem.

The Athlete’s Heart on ECG

Regular intense training reshapes the heart. The chambers may enlarge, the walls may thicken slightly, and the electrical system adapts. These changes collectively called “athlete’s heart” produce ECG findings that can look alarming to a physician unfamiliar with sports cardiology. Common benign findings include a slower-than-normal resting heart rate (sinus bradycardia), taller QRS voltages from chamber remodeling, and patterns of early repolarization that can mimic the ST changes seen in heart disease.¹⁷

The challenge is that some of these patterns overlap with features of cardiomyopathy or other structural heart diseases that carry a genuine risk of sudden cardiac death during exertion.¹⁸ International consensus guidelines have been developed to help clinicians distinguish the two, classifying ECG findings in athletes into categories ranging from normal training adaptations to patterns that warrant further investigation. Without these guidelines, an athlete could end up pulled from competition unnecessarily, or, worse, a dangerous condition could be dismissed as “just an athletic heart.” The type and intensity of sport also matter: endurance athletes tend to develop more chamber dilation and slower resting rates, while strength-trained athletes show more wall thickening. These sport-specific patterns are an active area of research.

Echocardiogram Versus Electrocardiogram

The similarity in names causes genuine confusion, but these are fundamentally different tests. An electrocardiogram (ECG) records electrical signals. An echocardiogram uses ultrasound to create moving images of the heart’s physical structure, showing chambers, valves, and the motion of the heart walls in real time. Echocardiography is one of the most widely used imaging tools for assessing heart anatomy and function, and left ventricle ejection fraction, a measure of how much blood the heart pumps out with each beat, is one of its most important clinical outputs.¹⁹

The two tests answer different questions. An ECG tells you about rhythm disturbances, conduction delays, ischemia, and electrical signs of chamber enlargement. An echocardiogram tells you about valve leaks, wall-motion abnormalities, fluid around the heart, and how well the heart is actually pumping. They complement each other. A patient with an ECG showing voltage criteria for hypertrophy might get an echocardiogram to confirm whether the walls truly are thickened and to measure the ejection fraction. A patient whose echocardiogram shows a dilated chamber might get an ECG to look for associated rhythm problems. Neither test replaces the other.

Fetal Heart Monitoring

Electrocardiography is not limited to adults. In obstetrics, fetal ECG monitoring has been explored as an adjunct to standard electronic fetal heart rate monitoring during labor. The idea is that analyzing the shape of the fetal ECG waveform, particularly changes in the ST segment, could provide earlier warning of fetal distress. A Cochrane review pooling data from six trials involving over 26,000 women found that adding ST waveform analysis to standard monitoring did not clearly reduce cesarean section rates or the number of babies born with severe metabolic acidosis or brain injury. It did reduce the need for fetal scalp blood sampling during labor, a minor procedural benefit.²⁰ Fetal ECG thus remains a supplementary tool rather than a replacement for existing monitoring, at least based on current evidence.

Pediatric ECGs, meanwhile, are interpreted differently from adult ones because normal values for heart rate, intervals, and wave amplitudes shift dramatically with age. A newborn’s heart rate of 140 beats per minute would be alarming in an adult but perfectly normal in an infant. Similarly, the pattern of dominant right ventricular forces seen on a newborn’s ECG reflects the physiology of fetal circulation and gradually shifts to the left-dominant pattern familiar in adults over the first months of life. Clinicians who interpret pediatric ECGs need age-specific reference ranges, and applying adult criteria to a child’s tracing can lead to false diagnoses in both directions.

When a Phonocardiogram or Other “Cardiogram” Comes Up

The word “cardiogram” occasionally appears in contexts beyond the standard ECG. A phonocardiogram, for instance, records the sounds the heart makes rather than its electrical activity. Microphones placed on the chest pick up the vibrations of closing valves and turbulent blood flow, producing a visual trace of heart sounds and murmurs. Research has used simultaneous ECG recording alongside phonocardiography, with the QRS complex of the ECG serving as a time marker for the start of each cardiac cycle to help identify and characterize murmurs in the acoustic signal.²¹ Phonocardiography is largely a research and teaching tool today, but it illustrates a broader point: the heart produces electrical signals, mechanical motion, sound waves, and pressure changes, and different types of “cardiograms” capture different facets of the same beating organ. The electrocardiogram dominates clinical practice because electrical signals travel instantly through body tissue, can be picked up with simple adhesive electrodes, and provide an extraordinary amount of diagnostic information for the cost and effort involved.